Prof Mona Bafadhel: key facts
- Kind of voice
- Academic
- Role
- NIHR Research Professor and Director of the King's Centre for Lung Health, King's College London
- Quoted on
- Respiratory (asthma/COPD)
- Tracked press citations
- 3
- Most recently quoted
- 30 Sept 2026
- First quoted
- 8 Sept 2026
“Identifying the patients with this type of inflammation means that we can be much more precise in our treatments. This is because the drug will be able to accurately bind to these types of cells to block the inflammatory response.”
What Prof Mona Bafadhel has said
“demonstrated that dupilumab significantly reduced the risk of severe exacerbations requiring hospitalisation and/or emergency department (ED) visits by 38% versus placebo”
King's Centre for Lung Health, King's College London, UK · Respiratory (asthma/COPD) · 30 Sept 2026 · Spotlight on Dupilumab: New Clinical Data in Asthma and COPD ↗
“This could be a gamechanger for people with asthma and COPD. Treatment for asthma and COPD exacerbations have not changed in 50 years, despite causing 3.8m deaths worldwide a year combined.”
Lead investigator, King's College London · Respiratory (asthma/COPD) · 8 Sept 2026 · Doctors hail first breakthrough in asthma and COPD treatment in 50 years ↗
Where Prof Mona Bafadhel has been quoted
- Revolutionary COPD injection given to patients for first timekcl.ac.uk · 30 Sept 2026
- Spotlight on Dupilumab: New Clinical Data in Asthma and COPDemjreviews.com · 30 Sept 2026
- Doctors hail first breakthrough in asthma and COPD treatment in 50 yearstheguardian.com · 8 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.